GC
Genelux Corporation Common Stock
🇺🇸XNAS.GNLXUnited StatesHealthcare
$2.38USDdown -0.08 (-3.25%)OpenDelayed3:31 PM
Price$2.38-0.08 (-3.25%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US36870H1032
- CUSIP
- 36870H103
Company
- Employees
- 25
- Headquarters
- Westlake Village, United States
- Website
- https://www.genelux.com
- CEO
- Mr. Thomas D. Zindrick J.D.
Market
- Shares outstanding
- 45.2M
- Market cap
- $107.68M
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $111.3M
- EPS LTM
- -$0.75calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -3.19calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $8K-99.41%down year on year
- Net income
- -$33.79M-11.19%down year on year
- Gross margin
- -1,762.5%-6,191.92%down year on year
- Free cash flow
- -$28.68M-25.74%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.